网站首页期刊介绍通知公告编 委 会投稿须知电子期刊广告合作联系我们
最新消息:
维持性血液透析患者血清RAGE、VDR表达与血管钙化的关系
作者:魏书彬  赵敏  薛痕 
单位:雅安市人民医院 肾脏内科, 四川 雅安 625000
关键词:维持性血液透析 血管钙化 晚期糖化终末产物受体 维生素D受体 
分类号:R459.5
出版年·卷·期(页码):2022·50·第十一期(1376-1381)
摘要:

目的:探讨晚期糖化终末产物受体(RAGE)、维生素D受体(VDR)在维持性血液透析(MHD)患者血清中的水平变化及与血管钙化的关系。方法:选取2019年12月至2020年12月在本院血液透析室治疗时间大于6个月的MHD患者105例为研究对象,其中无钙化组30例,轻度钙化组45例,重度钙化组30例。采用酶联免疫吸附法检测RAGE、VDR水平;Pearson法分析RAGE与VDR表达的相关性;受试者工作特征(ROC)曲线评价血清RAGE和VDR水平对MHD患者发生血管钙化的诊断价值;采用多因素Logistic回归分析血管钙化发生的影响因素。结果:重度钙化组患者血清中VDR表达水平低于无钙化组和轻度钙化组,且轻度钙化组低于无钙化组;重度钙化组患者RAGE表达水平高于无钙化组和轻度钙化组,且轻度钙化组高于无钙化组,差异均有统计学意义(P<0.05)。与无钙化组相比,轻度钙化组和重度钙化组患者血清中全段甲状旁腺激素(iPTH)、血钙(Ca)、血磷(P)水平以及钙化评分均升高(P<0.05);RAGE与iPTH、血Ca、血P、钙化评分均呈正相关,VDR与iPTH、血Ca、血P、钙化评分均呈负相关(P<0.05)。Pearson法分析结果显示,MHD患者血清中RAGE、VDR表达呈负相关(r=-0.345,P<0.05);Logistic回归分析结果显示,VDR、RAGE、iPTH、血Ca、血P均是影响血管钙化发生的独立危险因素(P<0.05);ROC曲线显示,VDR、RAGE水平预测MHD患者血管钙化的曲线下面积(AUC)分别为0.902、0.861,对应的敏感度分别为78.67%、74.67%,特异度分别为90.00%、86.67%,二者联合预测的AUC为0.905,敏感度为72.00%,特异度为96.67%。结论:MHD患者血管钙化程度与RAGE、VDR表达相关,RAGE表达随着血管钙化严重程度增加而上升,VDR表达随着血管钙化严重程度增加而下降,二者联合检测对MHD患者血管钙化的发生具有较高的诊断效能。

Objective: To investigate the changes in serum levels of receptor for advanced glycation end products(RAGE) and vitamin D receptor(VDR) in patients with maintenance hemodialysis(MHD) and their relationship with vascular calcification. Methods: From December 2019 to December 2020, 105 patients with MHD who were treated in the hemodialysis room of our hospital for more than 6 months were gathered as the research objects. Among them, 30 cases were in the non- calcification group, 45 cases in the mild calcification group, and 30 cases were in the severe calcification group. Enzyme-linked immunoassay was performed to measure the RAGE and VDR levels; Pearson method was performed to analyze the correlation between RAGE and VDR expression; receiver operating characteristic(ROC) curve was performed to evaluate the value of serum RAGE and VDR levels in the diagnosis of vascular calcification in MHD patients; multivariate Logistic regression analysis was used to analyze the influencing factors of vascular calcification. Results: The expression level of VDR in the severe calcification group was lower than that in the non-calcification group and the mild calcification group, and the mild calcification group was lower than the non-calcification group; the expression level of RAGE of patients in the severe calcification group was higher than that in the non-calcification group and the mild calcification group, and the mild calcification group was higher than the non-calcification group, the differences were statistically significant(P<0.05). Compared with the non-calcification group, the levels of serum parathyroid hormone(iPTH), blood calcium(Ca), blood phosphorus(P) and calcification scores in the mild calcification group and severe calcification group were increased(P<0.05); RAGE was directly correlated with iPTH, blood Ca, blood P, and calcification score, and VDR was inversely correlated with iPTH, blood Ca, blood P, and calcification score(P<0.05). Pearson method analysis showed that the expression of RAGE and VDR in serum of MHD patients was obviously nagatively correlated(r=-0.345, P<0.05); Logistic regression analysis showed that VDR, RAGE, iPTH, blood Ca, and blood P were all independent risk factors affecting the occurrence of vascular calcification(P<0.05); the ROC curve showed that the area under the curve(AUC) of VDR and RAGE levels predicting vascular calcification in MHD patients was 0.902 and 0.861, respectively, the corresponding sensitivity was 78.67% and 74.67%, and the specificity was 90.00% and 86.67%. The joint predicted AUC was 0.905, the sensitivity was 72.00%, and the specificity was 96.67%. Conclusion: The degree of vascular calcification in MHD patients is related to the expression of RAGE and VDR. The expression of RAGE increases with the severity of vascular calcification, and the expression of VDR decreases with the severity of vascular calcification. The combined detection of the two has a high diagnostic efficiency for the occurrence of vascular calcification in MHD patients.

参考文献:

[1] NITTA K,HANAFUSA N,OKAZAKI M,et al.Association between risk factors including bone-derived biomarkers and aortic arch calcification in maintenance hemodialysis patients[J].Kidney Blood Press Res,2018,43(5):1554-1562.
[2] EL BAZ T Z,KHAMIS O A,EL SHEHABY A,et al.Relationship between serum osteoprotegerin and vascular calcifications in hemodialysis patients[J].Egypt Heart J,2017,69(2):149-155.
[3] 张新,王晓慧,何泳,等.VDR基因多态性与维持性血液透析患者肾性骨营养不良的关系[J].临床肾脏病杂志,2018,18(11):682-686.
[4] 贺晓蕾,徐雪英,张欣洲.维生素D受体基因多态性与持续性非卧床腹膜透析肾性骨营养不良患者血管钙化的关系[J].山西医药杂志,2017,46(5):548-551.
[5] 白云鹏,马晓忠,刘现坤,等.晚期糖基化终末产物受体与主动脉瓣钙化发病机制的相关性研究[J].中国心血管病研究,2021,19(11):986-989.
[6] 卢伟军,叶建美,王静,等.内源性分泌型晚期糖基化终产物受体水平与冠状动脉粥样硬化的相关性[J].中华高血压杂志,2020,28(11):1070-1072.
[7] KAUPPILA L I,POLAK J F,CUPPLES L A,et al.New indices to classify location,severity and progression of calcific lesions in the abdominal aorta:a 25-year follow-up study[J].Atherosclerosis,1997,132(2):245-250.
[8] KARA A V,ALDEMIR M N,SOYLU Y E,et al.Relationship between serum vitamin D levels and health-related quality of life in maintenance hemodialysis patients[J].Blood Purif,2019,48(1):67-75.
[9] LEE C T,LEE Y T,TAIN Y L,et al.Circulating microRNAs and vascular calcification in hemodialysis patients[J].J Int Med Res,2019,47(7):2929-2939.
[10] WAZIRI B,DIX-PEEK T,DICKENS C,et al.Influence of vitamin D receptor polymorphisms on biochemical markers of mineral bone disorders in South African patients with chronic kidney disease[J].BMC Nephrol,2018,19(1):30.
[11] 郑峰,王福荣,许喆.维生素D受体基因多态性与青海地区藏族绝经后女性骨质疏松性骨折易感性的关系[J].中国现代医学杂志,2021,31(20):35-41.
[12] 张道法,陈道军,武伟,等.腹膜透析和血液透析对终末期肾脏疾病患者钙磷代谢及微炎症状态的影响[J].现代生物医学进展,2018,18(17):3360-3364.
[13] 曹珊,陈清萍,刘玉.腹膜透析患者血管钙化和感染与维生素D受体基因多态性的关联性[J].中华医院感染学杂志,2021,31(11):1644-1649.
[14] MACLEAN M,DERK J,RUIZ H H,et al.The receptor for advanced glycation end products(RAGE) and DIAPH1:implications for vascular and neuroinflammatory dysfunction in disorders of the central nervous system[J].Neurochem Int,2019,126(1):154-164.
[15] 李莉,陈晨,戴洪彬.维吾尔族2型糖尿病性骨质疏松症患者晚期糖基化终产物、受体的表达及其与腰椎骨密度的相关性[J].实用预防医学,2021,28(7):846-848.
[16] 刘晓辉,崔舜.晚期糖基化终末产物受体及其配体在骨代谢疾病中作用的研究进展[J].中国临床新医学,2021,14(2):201-205.

服务与反馈:
文章下载】【发表评论】【查看评论】【加入收藏
提示:您还未登录,请登录!点此登录
您是第 752649 位访问者


 ©《现代医学》编辑部
联系电话:025-83272481;83272479
电子邮件: xdyx@pub.seu.edu.cn

苏ICP备09058541